Your session is about to expire
← Back to Search
Neostigmine + Atropine for Post-Dural Puncture Headache
Study Summary
This trial is testing if neostigmine + atropine is better than usual care at reducing the number of postpartum women with a PDPH who need an EBP after an accidental dural puncture.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have asthma.Your pain score is less than 4 on a scale from 0 to 10.You have a condition called heart block.You have difficulty understanding and answering questions about pain and other information.Your body temperature is higher than 38.5 degrees Celsius.You experienced a headache within 72 hours after giving birth.You have a heart rhythm problem.You cannot take acetaminophen or NSAIDs for medical reasons.You have had migraines in the past.You have myasthenia gravis.You have had a procedure called epidural blood patch for this headache.You have a headache after a specific type of needle was used for pain relief during childbirth, and there is no other reason for the headache.
- Group 1: Postpartum dural puncture headache following dural puncture from Tuohy needle
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
For what clinical purposes is Neostigmine typically administered?
"Neostigmine has been found to be efficacious in managing ureteric colic, laughing episodes, and changes in pupil size."
What other research has examined the efficacy of Neostigmine?
"Currently, there are 32 Neostigmine clinical trials taking place around the world. Of these live studies, 7 have reached Phase 3 status. Most of the sites investigating this medication are located in San Antonio but many other locations across 157 cities are also conducting research on it."
Is participation in this research study open to individuals aged 60 and over?
"The requirements to take part in this study state that the age of participants should be within 18 and 54."
Is there still an opportunity for participants to join this research endeavor?
"Affirmative. Per the information stored on clinicaltrials.gov, this study is actively seeking patients for recruitment; it was initially posted on November 19th 2021 and last updated December 1st 2021. 18 participants are needed from a single medical centre to participate in the trial."
What is the participant count of this research project?
"Affirmative. According to the data provided by clinicaltrials.gov, this trial is actively seeking participants; it was first published on November 19th 2021 and most recently updated on December 1st 2021. The researchers are looking for 18 recruits from a single site."
Has Neostigmine been granted permission by the FDA for use?
"Our team at Power gave Neostigmine a rating of 2 on the safety scale, as it is in Phase 2 and has evidence supporting its security but no proof backing up its effectiveness."
Is there a specific demographic that can partake in this scientific research?
"The requirements for this clinical trial dictates that candidates should be aged between 18 and 54, have post-dural puncture headache, and must agree to participate in the study. A total of 18 participants are needed."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger